Vor Biopharma VOR
NASDAQ VOR
$20.09 +0.53 (+2.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Vor Biopharma (VOR) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Vor Biopharma (VOR) posted Depreciation & Amortization (CF) of $39,000 for Q3 2026, down 98.1% from $2.1 million a year earlier but up 8.3% from the prior quarter.

Analysis

Vor Biopharma (VOR) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Depreciation & Amortization (CF) at Vor Biopharma was $103,000, down 98.2% year-over-year; for FY2025, it came in at $2.9 million, down 17.8% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 36.8% (FY2020 to FY2025).
  • In prior years, Vor Biopharma's Depreciation & Amortization (CF) was $3.53 million in FY2024 (+0.8%), $3.5 million in FY2023 (+38.6%), $2.53 million in FY2022 (+76.1%) and $1.43 million in FY2021 (+137.0%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $28,000 in Q1 2026 to a high of $2.1 million in Q3 2025 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last three quarters, with an average decline of 6.7% over the last seven quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q3 2022, with growth of 200.0%; the weakest was Q2 2026, with a decline of 98.3%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Vor Biopharma 1.20 Bn -692.85 Mn - 39,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 39,000.00
Jun 30, 2026 36,000.00
Mar 31, 2026 28,000.00
Sep 30, 2025 2.10 Mn
Jun 30, 2025 2.10 Mn
Mar 31, 2025 825,000.00
Dec 31, 2024 828,000.00
Sep 30, 2024 900,000.00
Jun 30, 2024 900,000.00
Mar 31, 2024 943,000.00
Dec 31, 2023 900,000.00
Sep 30, 2023 900,000.00
Jun 30, 2023 900,000.00
Mar 31, 2023 837,000.00
Dec 31, 2022 625,000.00
Sep 30, 2022 900,000.00
Jun 30, 2022 600,000.00
Mar 31, 2022 426,000.00
Dec 31, 2021 395,000.00
Sep 30, 2021 300,000.00
API Access

Vor Biopharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VOR&period=max&api_key=YOUR_API_KEY